Home >> Blog >> Medi Assist Healthcare Services IPO: Review, Valuation & GMP
Medi Assist Healthcare Services IPO: Review, Valuation & GMP
Table of Contents
- Medi Assist Healthcare IPO - Complete Overview
- Medi Assist Healthcare IPO Overview
- Company Financial
- The Objective of the Issue
- Promoters and Management of Medi Assist Healthcare IPO
- Medi Assist Healthcare IPO Lead Managers
- Peers of Medi Assist Healthcare IPO:
- Evaluation
- Dividend Policy
- IPO's Strengths
- IPO's Weaknesses
- IPO GMP Today
- Conclusion
Medi Assist Healthcare IPO - Complete Overview
Medi Assist Healthcare Services Limited, founded in June 2002, is a health-tech and insurance-tech company. It manages health benefits for employers, retail members, and public health schemes, mainly serving insurance companies.
The company acts as a mediator between insurance companies, insured members, healthcare providers (like hospitals), and the government. As of March 31, 2023, it collaborates with 36 insurance companies globally.
Medi Assist is based in Bengaluru and is India's largest health benefits administrator, handling health insurance policies' revenues and premiums for the financial years 2018, 2019, and 2020. It operates under TPA Regulations, primarily serving insurance companies but also acting as an intermediary between insurance companies, insured members, healthcare providers, and the government.
In 2020, Medi Assist managed Rs. 7,829.5 crores of health insurance premiums and held a 17% market share of the private health insurance market. The company has a Pan-India healthcare provider network of over 11,000 hospitals.
As of FY 2023, Medi Assist managed health insurance premiums totaling INR 14,574.65 crore, with a significant growth rate. The company collaborates with 36 insurance entities globally and is India's largest health benefits administrator, serving over 9,500 group accounts across sectors.
Medi Assist has built an extensive healthcare provider network across India, comprising 14,301 hospitals in 967 cities and towns across 32 states and union territories. In FY 2023, the company facilitated the settlement of 5.27 million claims, including in-patient and outpatient claims.
Medi Assist Healthcare IPO Overview
Medi Assist Healthcare IPO date is slated to be open for subscription from January 15, 2024, to January 17, 2024. This BSE SME IPO follows a Book Built Issue IPO.
Medi Assist Healthcare IPO price is fixed at Rs. 397 - Rs. 418 per share. The upcoming BSE NSE IPO listing date will be updated soon.
The total issue size of this IPO amounts to Rs.1,171.58 CR. The company has reserved 50% for institutional investors, 15% for non-institutional investors, and 35% for retail investors.
Medi Assist Healthcare IPO timetable (Tentative)
Events |
Date |
IPO Opening Date |
15 January 2024 |
IPO Closing Date |
17 January 2024 |
IPO Allotment Date |
18 January 2024 |
Refund initiation |
19 January 2024 |
IPO Listing Date |
22 January 2024 |
Medi Assist Healthcare IPO Details
IPO opening & closing date |
15 January to 17 January 2024 |
Face value |
Rs. 5 per share |
Issue Price |
Rs. 397 - Rs. 418 per share |
Lot Size |
35 share |
Price of 1 lot |
Rs. 14,630 |
Total Issue Size |
28,028,168 shares (aggregating up to Rs.1,171.58Cr) |
Offer for sale |
28,028,168 shares of Rs. 5 (aggregating up to Rs.1,171.58 Cr) |
Listing at |
BSE NSE |
Issue Type |
Book Built Issue IPO |
Registrar |
Link Intime India Private Ltd |
Medi Assist Healthcare IPO Lot Details
Application |
Lot |
Shares |
Minimum Lot Investment (Retail) |
1 lot |
35 |
Maximum Lot Investment (Retail) |
13 lot |
455 |
Minimum Lot Investment (HNI) |
14 lot |
490 |
Maximum Lot Investment (HNI) |
68 lot |
2380 |
Medi Assist Healthcare IPO Reservation
QIB Shares Offered |
Maximum 50% |
Retail Shares Offered |
Minimum 35% |
Other Shares Offered |
Minimum 15% |
Revenue By operations
As of September 30, FY23, the company's total revenue saw an increase from the previous year, with core operations and additional income contributing to the overall growth.
(amount in Crore)
Particulars |
Sep 30 FY 23 |
Mar 31 FY 23 |
Mar 31 FY 22 |
Revenue from operations |
3,01.95 |
5,04.93 |
3,93.81 |
Other Operating Income |
10.07 |
14.02 |
18.21 |
Total Revenue from operations |
3,12.02 |
5,18.95 |
4,12.02 |
Company Financial
As of September 30, FY23, the company's assets, revenue, profit, net worth, and reserve & surplus all showed positive growth compared to the previous financial year.
(Amount in Cr.)
Period |
Sep 30 FY 23 |
Mar 31 FY 23 |
Mar 31 FY 22 |
Total Assets |
802.62 |
705.72 |
602.23 |
Total Revenue |
312.03 |
518.96 |
412.02 |
PAT |
22.49 |
74.04 |
64.22 |
Net worth |
416.64 |
383.67 |
339.29 |
Reserve & Surplus |
102.03 |
353.86 |
308.63 |
The Objective of the Issue
-
Equity shares listing aims to enhance visibility and brand recognition.
-
Providing liquidity to existing shareholders is a key objective.
-
The company will not receive proceeds; all funds go to selling shareholders in proportion to their offered equity shares.
Promoters and Management of Medi Assist Healthcare IPO
1. Dr. Vikram Jit Singh Chhatwal.
2. Medimatter Health Management Private Limited.
3.Bessemer India Capital Holding II Ltd.
Pre-issue Promoter Shareholding |
67.55% |
Post-issue Promoter Shareholding |
45.75% |
Medi Assist Healthcare IPO Lead Managers
-
Axis Bank Limited
-
Iifl Securities Ltd
-
Nuvama Wealth Management Limited
-
SBI Capital Markets Limited
Peers of Medi Assist Healthcare IPO:
There are no listed companies in India that engage in a business similar to that of their Company.
Therefore, it is not possible to provide an industry comparison in relation to their Company.
Evaluation
Particulars |
P/E (X) |
EPS (Rs) |
Pre IPO |
38.87 |
10.75 |
Post IPO |
64 |
6.53 |
The IPO (Initial Public Offering) is priced between Rs. 397 and Rs. 418 per share. When we check the P/E (Price-to-Earnings) ratio using the earnings from the previous year, it is 38.86x. However, if we use the expected earnings after the IPO, the P/E ratio becomes 64x.
So, the IPO is priced at a P/E ratio between 38.86x and 64x. Comparing this with the average industry P/E ratio of 15.16, it suggests that the IPO may be considered highly overvalued.
Dividend Policy
The company hasn't paid dividends in past fiscal years. Whether we can pay them in the future depends on factors like profits, past dividend trends, capital needs, legal restrictions, and other relevant considerations evaluated by our Board. They aim to pay 50-75% of their profits as dividends and might pay an extra 25% from past earnings. If dividends are more than ₹1,500, they'll be sent electronically.
IPO's Strengths
1. Industry Advantage: Well-positioned in a thriving industry.
2. Market Leader: Largest health benefits administrator in India.
3. Strong Partnerships: Long Standing relationships with major Indian insurance companies.
4. Nationwide Contracts: Attractive agreements with a pan-India healthcare provider network.
IPO's Weaknesses
1. Revenue Dependency: Future earnings hinge on managed premium growth.
2. Tech Vulnerability: Brand reputation at risk due to technology dependence.
3. Client Loss Impact: Adverse effect on business and prospects from client loss.
4. Regulatory Compliance: Non-compliance with IRDAI standards poses a significant risk.
IPO GMP Today
The latest GMP of Medi Assist Healthcare IPO is Rs.35.
Conclusion
The upcoming IPO of Medi Assist Healthcare Services Limited is set to open for subscription from January 15, 2024, to January 17, 2024. The company, founded in 2002, is a prominent player in the health-tech and insurance-tech sector, managing health benefits for various clients, including insurance companies. The IPO price ranges from Rs. 397 to Rs. 418 per share.
The company's financials and operational strengths highlight its significant market presence and partnerships with major insurance firms. However, potential weaknesses include revenue dependency on premium growth and vulnerability to technology-related risks. The IPO's Price-to-Earnings (P/E) ratio is between 38.86x and 64x, which, when compared to the industry average of 15.16, suggests a potential overvaluation
Disclaimer:
Please note that this blog is not any recommendation for buying or selling any stock. We always encourage the reader to do their research before investing in any stock
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP.
Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.
Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock market.
Frequently Asked Questions
Medi Assist is a health-tech and insurance-tech company managing health benefits for employers, retail members, and public health schemes, primarily serving insurance companies
It is India's largest health benefits administrator with extensive collaborations, a nationwide network of over 11,000 hospitals, and handling significant health insurance premiums.
As of FY 2023, the company managed health insurance premiums worth INR 14,574.65 crores, showing substantial growth. Financial figures include total assets, revenue, PAT, net worth, and reserve & surplus.
The IPO aims to enhance visibility, provide liquidity to existing shareholders, and increase the company's brand presence.
Strengths include industry advantage, market leadership, strong partnerships, and nationwide contracts. Weaknesses encompass revenue dependency, tech vulnerability, client loss impact, and regulatory compliance risks.
Liked What You Just Read? Share this Post:
Viewer's Thoughts
TheMukulAgrawal | Posted on 13/01/2024
@RAHULCHAUDHRY Thank you for your suggestion sir, we have updated all the details.
RAHUL CHAUDHRY | Posted on 12/01/2024
This blog needs to be some updates. Otherwise this is fantastic information provided by your side sir ji. 🙏🙏🙏